Sprout Pharmaceuticals
Latest Stories
FemaleViagra.jpg
A tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters. Sprout has succeeded where many of the world's largest pharmaceutical companies have failed: in winning Food and Drug Administration approval for flibanserin, dubbed Addyi, the first drug to boost women's sexual desire. (Associated Press)
99554541f6457418780f6a706700d259.jpg
The panel of Food and Drug Administration advisers voted 18-6 in favor of Sprout Pharmaceutical's daily pill, flibanserin, on the condition that the company develops a plan to manage its risks. (Associated Press)
dc2081fdbc5c65076e0f6a706700923f.jpg
In this Friday, Sept. 27, 2013, file photo, a tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters. The pill has been twice rejected, but Sprout Pharmaceuticals said Tuesday, Feb. 17, 2015, it is refiling its application for flibanserin, adding new information requested by the Food and Drug Administration about how the pill affects driving ability. (AP Photo/Allen G. Breed, File)
767ff64deda188054b0f6a706700614f.jpg
FILE - In this Friday, Sept. 27, 2013, file photo, a tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters. Sprout Pharmaceuticals said Tuesday, Feb. 11, 2014, that the Food and Drug Administration wants to see more data on how the company's drug, flibanserin, interacts with other medications and how it affects driving ability. Nearly 10 percent of women studied in company trials reported sleepiness while taking the daily pill. (AP Photo/Allen G. Breed)
